MedPlus Health Services Limited IPO GMP, Lot Size, Allotment date will be discussed here. Medplus Health Services was founded in 2006 and is India’s second-largest pharmacy retailer in terms of shop count and revenue. Pharmaceutical and wellness items, such as pharmaceuticals, vitamins, medical gadgets, and test kits, are available, as well as fast-moving consumer goods, such as home and personal care products, infant care products, sanitizers, soaps, and detergents.
MedPlus Health Services Limited IPO
It is also the first pharmacy retailer in India to provide an omnichannel platform that allows consumers to buy items in shops, over the phone, online, and via a Click & Pick service. MedPlus Health Services Limited IPO. The IPO for MedPlus Health will take place between December 13 and December 16.
Price range: 780-796 rupees per share. Lot size: One lot consists of 18 shares, with subsequent lots comprised of multiples of 18 shares. The Rs 1,398 crore IPO comprises a Rs 600 crore new issue of shares and an OFS of Rs 798.30 crore. The most likely date for the allotment of MedPlus Health IPO shares is December 20. MedPlus Health is expected to list on the BSE and NSE on December 23.
MedPlus Health Services Limited Allotment Date 2021
GMP of the MedPlus Health IPO: There is currently no information available on the grey market premium of the impending public offering. MedPlus Health Services Limited Competitive advantages. In India, it is the second-biggest pharmacy store. Customer value proposition and strong brand identity.
In Tamil Nadu, Andhra Pradesh, Telangana, Karnataka, Odisha, West Bengal, and Maharashtra, there are about 2000 pharmacies. Customers are the first to benefit from an Omni-channel platform provided by a pharmacy. Management staff that is highly qualified, experienced, and competent. Review of the Medplus Health Services Limited Initial Public Offering.
MedPlus Health Services Limited IPO Price 2021
Following a poor performance in FY20, the firm produced excellent results, and its IPO was priced aggressively based on these results. While the future viability of such margins is a problem, the IPO price also looks to be excessive. Some cash surplus investors may contemplate a long-term investment, while others may dismiss it.
Give specifics – The public offering comprises a new issuance of 600 crore shares and an offer for sale (OFS) of 798.29 crore shares by selling shareholders, for a total of Rs 1,398.29 crore. Through the offer for sale, PI Opportunities Fund-I would sell shares worth Rs 623 crore, and SS Pharma LLC will sell shares worth Rs 107 crore.
MedPlus Health Services Limited Lot Size 2021
Shore Pharma LLC, Natco Pharma, Time Cap Pharma Labs, A. Raghava Reddy, K. Prakurthi, Navdeep Patyal, Sangeeta Raju, R. Venkat Reddy, T.K. Kurien, Nithya Venkataramani, Atul Gupta, Manoj Jaiswal, Rahul Garg, Kollengode Ramanathan Lakshminarayana, Bijou Kurien, Atul Gupta
Employees of the firm will be given a reserve of shares worth Rs 5 crore as part of the offer. Employees who qualify will get shares at a discount of Rs 78 per share compared to the final offer price. Qualified institutional purchasers will get half of the net issue, non-institutional bidders will receive 15%, and retail investors will receive 35%.
The problem’s objectives – MedPlus Health Services Share Info – The proceeds from the new issuance will be used to meet the working capital needs of the subsidiary Optical Health Solutions and general company reasons. The size of the lot and the part earmarked for investors Investors may place bids for a minimum of 18 equity shares and then in multiples of 18 shares after that. A minimum of Rs 14,328 for one lot and a maximum of Rs 1,86,264 for 13 lots is available to retail investors.
Industry and company profile – Gangadi Madhukar Reddy, the managing director and chief executive officer launched the firm in 2006. His objective was to create a recognized pharmacy retail brand that provides authentic drugs and better value to customers by decreasing supply chain inefficiencies via technology.
As of March 31, 2021, Medplus has grown from 48 shops in Hyderabad to India’s second-biggest pharmacy retail network, with over 2,000 locations throughout Tamil Nadu, Andhra Pradesh, Telangana, Karnataka, Odisha, West Bengal, and Maharashtra.
MedPlus Health Services IPO Today 2021
It has a significant part of the organized pharmacy retail industry in these states, accounting for around 30% of revenue from operations in Chennai, 29% in Bengaluru, 30% in Hyderabad, and 22% in Kolkata.
In 2015, Medplus became the first pharmacy store in India to provide an omnichannel platform, and in fiscal 2020, it began aggressively concentrating on online sales.
A real-time inventory analytics platform drives the company’s supply chain, complemented by an algorithm-driven automated replenishment and stock selection system. It usually buys its stock from pharmaceutical firms directly.
MedPlus Health Services Stock Price
Medplus made a profit of Rs 63.11 crore in FY21, up from Rs 1.79 crore the previous year. Revenue climbed to Rs 3,069.26 crore from Rs 2,870.6 crore during the same time.
The profit for the six months ending September 2021 was Rs 66.36 crore, up from Rs 22.27 crore the previous year, while sales were Rs 1,879.92 crore, up from Rs 1,462.55 crore the last year.
|Official Portal||Click here|
|MPNRC Home||Click here|